Dr. Subramanian Iyer
Professor & Senior Surgical Oncologist
Surgical Oncologist
231 verified reviews
231
Recent Consultations
About Dr. Subramanian Iyer
Dr. Subramanian Iyer is a senior surgical oncologist at Tata Memorial Hospital in Mumbai, which is widely regarded as one of the finest cancer centres in Asia and treats more than 75,000 new cancer patients annually. With a career spanning nearly three decades, Dr. Iyer specialises in the surgical management of gastrointestinal and hepatobiliary cancers — an area requiring not only technical mastery but a deep understanding of oncology, as surgery is frequently combined with chemotherapy and radiation in multimodal treatment protocols.
He trained in surgery at the prestigious Grant Medical College before completing his post-doctoral work at Tata Memorial, and subsequently undertook a fellowship in hepato-pancreato-biliary (HPB) surgery at the University of Queensland in Australia. This fellowship equipped him with expertise in complex liver resections, Whipple procedures (pancreaticoduodenectomy), and bile duct reconstructions — procedures that require precision and carry significant technical challenge.
Dr. Iyer's work philosophy centres on the multidisciplinary tumour board model: every cancer patient under his care is reviewed by a team that includes medical oncologists, radiation oncologists, radiologists, and pathologists before a treatment plan is agreed. This ensures that no patient receives surgery when a non-surgical approach would achieve better outcomes, and vice versa.
He has also been closely involved in clinical research, contributing to multicentre trials on gastric cancer surgery and hepatocellular carcinoma resection. His publications appear in internationally indexed journals and have been cited in evidence-based oncology guidelines.
Conditions Treated by Dr. Subramanian Iyer
- Colorectal cancer
- Gastric (stomach) cancer
- Pancreatic cancer
- Hepatocellular carcinoma (liver cancer)
- Cholangiocarcinoma (bile duct cancer)
- Gallbladder cancer
- Oesophageal cancer
- Peritoneal carcinomatosis
- Gastrointestinal stromal tumours (GIST)
- Secondary liver metastases from colorectal cancer
Areas of Interest
- Hepato-pancreato-biliary (HPB) surgery
- Gastrointestinal oncology surgery
- Laparoscopic cancer surgery
- Cytoreductive surgery with HIPEC
- Liver resection for primary and secondary tumours
- Whipple procedure (pancreaticoduodenectomy)
- Multidisciplinary cancer management
- Clinical trials in GI oncology
Qualifications
- MBBS — Grant Medical College, Mumbai
- MS (General Surgery) — Grant Medical College, Mumbai
- MCh (Surgical Oncology) — Tata Memorial Hospital, Mumbai
- Fellowship in HPB Surgery — University of Queensland, Australia
Work Experience
- Professor & Senior Surgical Oncologist, Tata Memorial Hospital, Mumbai (2005 – Present)
- Associate Professor, Surgical Oncology, Tata Memorial Hospital, Mumbai (1999 – 2005)
- Clinical Fellow, HPB Surgery, University of Queensland, Australia
- Principal Investigator, INDOX Cancer Research Network, India
Certifications (2)
MCh Surgical Oncology
Tata Memorial Hospital, Mumbai — 1998
Fellowship in HPB Surgery
University of Queensland, Australia — 2000
Memberships (5)
- Association of Surgeons of India (ASI)
- Indian Association of Surgical Oncology (IASO)
- Society of Surgical Oncology (SSO), USA
- International Hepato-Pancreato-Biliary Association (IHPBA)
- American Society of Clinical Oncology (ASCO)
Research Papers & Publications (3)
Outcomes of pancreaticoduodenectomy for periampullary cancers in a high-volume Indian centre: a review of 1,200 cases
Annals of Surgical Oncology — 2019
Laparoscopic versus open right hemicolectomy for colon cancer: a randomised controlled trial
Colorectal Disease — 2021
Cytoreductive surgery and HIPEC for peritoneal carcinomatosis: a prospective Indian experience
Journal of Surgical Oncology — 2022
Procedures
Frequently Asked Questions
Tata Memorial Hospital treats over 75,000 new cancer patients annually, making it one of the highest-volume cancer centres in the world. High volume is directly associated with better surgical outcomes, and the hospital's multidisciplinary team model ensures every patient benefits from a comprehensive, evidence-based treatment plan.
